October 3, 2015
NATIONAL HARBOR, Md. — In this video, Clyde W. Yancy, MD, MSc, chief of cardiology at Northwest University Feinberg School of Medicine, Chicago, highlights a session on the management of HF among African Americans held at the Heart Failure Society of America Annual Scientific Meeting.
The session included a discussion of disparities in care, and an observed slower uptake in evidence-based therapies such as beta-blockers and cardiac devices among African Americans compared with other racial/ethnic. Yancy and colleagues discussed potential solutions for addressing these disparities, and also reviewed encouraging data that indicate significant increases in device therapy for this patient population and a “slow, iterative” rise in the use of other treatments.